ClinicalTrials.govpublic full text
Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation
prostate cancer, dna, androgen receptor abnormal, androgen receptor genomics, enzalutamide, prostatectomy, neoadjuvant androgen ablation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840426
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.